Implantable Drug Delivery Devices Market Size

  • Report ID: 3281
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Implantable Drug Delivery Devices Market size was valued at USD 29.4 billion in 2024 and is expected to reach USD 82.89 billion by 2037, registering around 8.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of implantable drug delivery devices is assessed at USD 31.47 billion.
 

The growth of the market can be attributed to the increasing prevalence of chronic diseases globally, such as cardiovascular diseases, auto-immune diseases, diabetes, and others. Additionally, the growing number of aging populations in various countries has increased the risk of getting chronic diseases. As a result, there is an increasing influx of patients for surgeries using implantable drug delivery devices, which is estimated to boost the market growth. According to World Health Organization (WHO), in 2020, approximately 10 million individuals have died due to cancer, and it has been recognized as the leading cause of death globally. Rising concern among governmental organizations for developing better medical devices to provide high-level safety standards to the patients has created significant growth opportunities for the implantable drug delivery device market over the forecast period. Moreover, the growing preference of the patients for drug delivery device products on the back of its high efficiency has also contributed towards the global market growth. 



Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of implantable drug delivery devices is assessed at USD 31.47 billion.

Implantable Drug Delivery Devices Market size was valued at USD 29.4 billion in 2024 and is expected to reach USD 82.89 billion by 2037, registering around 8.3% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is predicted to account for largest revenue share by 2037, on account of steadily increasing healthcare expenditure and rising concern & awareness for the development of advanced devices in the region.

The major players in the market include Boston Scientific Corporation, Merck & Co., Inc., Medtronic Plc, Allergan, Inc., Abbott Laboratories, DSM Biomedical, Varian Medical Systems, Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos